Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Remedi SeniorCare
AddedFeb 13, 2024
UpdatedJun 18, 2026
Remedi SeniorCare

Remedi SeniorCare

Remedi SeniorCare: Comprehensive pharmacy services and healthcare solutions provider across the US.

HQ
Baltimore, MD, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to revolutionize pharmacy services in the healthcare sector, Remedi SeniorCare provides comprehensive pharmacy solutions across the United States. The company's core vision is to enhance medication safety, accuracy, and efficiency through innovative technology and personalized care. Remedi SeniorCare offers a range of services including in-house starter dose pharmacy, medication delivery, interim supply, medical records management, collaborative support, infusion therapy, transition support, customized reporting, and education and training. Their flagship product, PAXIT®, is a 24-hour unit-dose medication system designed to improve safety and streamline the medication dispensing process.

Remedi SeniorCare has garnered attention for its technological advancements and commitment to quality care. Notable affiliations include partnerships with various healthcare facilities and senior care organizations. The company has attracted significant investment from leading healthcare investors, bolstering its growth and innovation capabilities. Key achievements include the widespread adoption of the PAXIT® system, which has significantly reduced medication errors and improved operational efficiency in nursing homes and other care facilities. Overall, Remedi SeniorCare has made a substantial impact on the healthcare industry by integrating technology with compassionate care to better serve the senior population.

Remedi SeniorCare - Quick Facts

When was Remedi SeniorCare founded?

Remedi SeniorCare was founded in 2017.

Where is Remedi SeniorCare's headquarters located?

Remedi SeniorCare's headquarters is located in Baltimore, MD, US.

When was Remedi SeniorCare's last funding round?

Remedi SeniorCare's most recent funding round was for $300M (USD) in August 2011.

How much has Remedi SeniorCare raised to-date?

As of Aug 7, 2011, Remedi SeniorCare has raised a total of $301M (USD).

How many employees does Remedi SeniorCare have?

Remedi SeniorCare has 7,500 employees as of Feb 4, 2024.

Remedi SeniorCare - Classification

Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Healthcare
  • Pharmacy
Tags
  • Healthtech
  • SaaS
NAICS
  • 456000Health and Personal Care Retailers
  • 450000Retail Trade
  • 456100Health and Personal Care Retailers
  • 456110Pharmacies and Drug Retailers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 5900Miscellaneous Retail
  • 2830Drugs
  • 5910Drug Stores And Proprietary Stores
  • 2834Pharmaceutical Preparations